| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |